Turkey’s Medicines and Medical Devices Agency (“TMMDA”) announced the information and documents that should be submitted via “online system” within the scope of “e-transformation in public” for import applications of blood products, human medicinal products containing blood products as well as immunological products starting as of 27 May 2019.

Pursuant to the Communiqué on Import Inspection of Certain Products Inspected by the Ministry of Health published in the 30 December 2018 dated Official Gazette, only the control and proforma invoices will be submitted physically, and the other information and documents requested according to the type of application will be via online system within the scope of e-transformation in public studies.